Cargando…
Cationic drugs and COVID-19
Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic group...
Autores principales: | Brenna, Oreste Vittore, Torretta, Sara, Pignataro, Lorenzo, Di Berardino, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557649/ https://www.ncbi.nlm.nih.gov/pubmed/33045858 http://dx.doi.org/10.1177/2058738420966078 |
Ejemplares similares
-
Looking at the day after COVID-19… what laryngeal sequelae should we expect?
por: Torretta, Sara, et al.
Publicado: (2021) -
Why Italian ENT physicians should be aware of SARS-CoV-2
por: Torretta, Sara, et al.
Publicado: (2020) -
Topically administered hyaluronic acid in the upper airway: A
narrative review
por: Pignataro, Lorenzo, et al.
Publicado: (2018) -
SARS-CoV-2 tropism across the upper aerodigestive tract
por: Torretta, Sara, et al.
Publicado: (2021) -
Surgical treatment of non-tuberculous mycobacterial lymphadenitis in
children: Our experience and a narrative review
por: Torretta, Sara, et al.
Publicado: (2018)